The authors' work is supported by the European Network for Translational Research in Atrial Fibrillation (EUTRAF, No. 261057), the German Federal Ministry of Education and Research (AF Competence ...

Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular ...

The first-line therapy for arrhythmogenic right ventricular cardiomyopathy (ARVC) is considered to be β-blockers, which are generally well tolerated. However, findings from the Multidisciplinary Study ...

“Currently, contemporary guidelines recommend a trial of antiarrhythmic drugs prior to considering catheter ablation,” Jason G. Andrade, MD, director of the Atrial Fibrillation Clinic, ...

An earlier version of this story stated that dronedarone was contraindicated in patients with NYHA class 2 or 3 heart failure. In fact, the drug is contraindicated ...

The New England Journal of Medicine ©2020. A recent report published in the New England Journal of Medicine describes the case of a patient with persistent skin discoloration associated with the use ...

High blood pressure in the lungs, known as pulmonary arterial hypertension (PAH), is a potentially fatal disease caused by obstruction of blood flow in the lungs. A new study in The American Journal ...

Flecainide acetate 50mg, 100mg+, 150mg+; tabs; +scored. Flecainide acetate has local anesthetic activity and belongs to the membrane stabilizing (Class 1) group of antiarrhythmic agents; it has ...

In this audio interview, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research being presented at the 2024 American Heart Association Scientific Sessions.